Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease […]

NEWPORT NEWS, Va., Dec. 07, 2024 (GLOBE NEWSWIRE) — HII (NYSE: HII) today christened Virginia-class submarine Arkansas (SSN 800) at […]

NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]

Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing HNSCC ongoing with clinical data update planned for 2025 Petosemtamab […]

VANCOUVER, British Columbia, Dec. 06, 2024 (GLOBE NEWSWIRE) — Rugby Resources Ltd. (“Rugby” or the “Company”) (TSX-V: RUG) is pleased […]

TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) — Sprott Asset Management LP (“Sprott Asset Management”), a subsidiary of Sprott Inc., on […]

TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) — Sprott Asset Management LP (“Sprott Asset Management”), a subsidiary of Sprott Inc., on […]

VANCOUVER, British Columbia, Dec. 06, 2024 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE:MEC, OTC:MECPF, FRA:92T) (“Mustang” or the “Company”) is excited […]